Gastroenterology / Editorial
Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
Hyun Phil Shin
Korean J Intern Med. 2023;38(4):454-455. Published online June 30, 2023
|